https://www.europeanpharmaceuticalreview.com/mhra-approves-new-combination-therapy-for-small-cell-lung-cancer/2136559.article European Pharmaceutical Review en 2026-09-25T09:00:00+01:00 MHRA approves new combination therapy for small cell lung cancer Medicine and Healthcare products Regulatory Agency (MHRA),Extensive-stage small cell lung cancer (ES-SCLC),Regulation and compliance https://www.europeanpharmaceuticalreview.com/amgen-reports-positive-topline-phase-3-sjögrens-results/2136534.article European Pharmaceutical Review en 2026-09-24T08:00:00+01:00 Amgen reports positive topline Phase 3 Sjögren’s results Clinical Trials,Clinical Development